Towards an economic evidence base for pharmacogenetics: consideration of outcomes is key.
D003362:Cost-Benefit Analysis; D016208:Databases, Factual; D003659:Decision Making, Organizational; D019317:Evidence-Based Medicine; D006295:Health Resources / Q000191:economics / Q000706:statistics & numerical data; D006801:Humans; D008780:Methyltransferases / Q000235:genetics; D010597:Pharmacogenetics / Q000191:economics* / Q000706:statistics & numerical data*; D019057:Quality-Adjusted Life Years; D016896:Treatment Outcome; D006113:United Kingdom
D008780:Methyltransferases; C022745:thiopurine methyltransferase